Premium
The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
Author(s) -
DODD J.,
TYLER J. P. P.,
CRANDON A. J.,
BLUMENTHAL N. J.,
FAY R. A.,
BAIRD P. J.,
HICKS L. J.,
HUDSON C. N.
Publication year - 1985
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1985.tb03003.x
Subject(s) - ovarian cancer , monoclonal antibody , immune system , antibody , cancer , antigen , antigen antibody complex , medicine , immunology , cancer research
Summary. The use of circulating immune complexes and a commercial monocolonal antibody to ovarian cancer (CA125 kit) in monitoring progress in patients with ovarian cancer has been assessed. While changes in immune complexes were apparent in some patients with active progression of disease, the marked change in values and linear trend make the use of CA125 a useful clinical marker.